Termedia.pl
 
 
ISSN: 1505-8409
Przewodnik Lekarza/Guide for GPs
Current issue Archive About the journal Supplements Abstracting and indexing Contact Instructions for authors
5/2007
vol. 10
 
Share:
Share:
abstract:

Asthma treatment with budesonide/formoterol in a single inhaler (Symbicort - Astra Zeneca) adjustable to needs (maintenance and reliever medication)

Mirosław Szmidt

Przew Lek 2007; 5: 87-93
Online publish date: 2007/09/07
View full text Get citation
 
Budesonide/formoterol – Symbicort (Astra Zeneca), a combination of budesonide, an inhaled corticosteroid providing an anti-inflammatory effect, and formoterol, a unique rapid and long-acting bronchodilator, which is delivered in one inhaler. The new treatment approach for asthma budesonide/formoterol maintenance and reliever therapy (SMART) is more effective than fixed doses of budesonide/formoterol or fluticasone/salmeterol. With adjustable maintenance dosing where patients step up or down their medication. Symbicort improves asthma control and quality of life, and reduces the number of a exacerbations at a smaller total dose of inhaled glucocorticosteroids in comparison with fixed dosing.
keywords:

asthma, budesonide/formoterol, maintence therapy, on demand

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.